IL-2-Expressing Tumor Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-2-Expressing Tumor Cells, covering 2014-02-03 to 2014-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells [Phase 1]